The Effect of Opiates on Patient Reported Outcomes After Ureteroscopy

Document Type

Conference Proceeding

Publication Date

4-2023

Publication Title

Journal of Urology

Abstract

INTRODUCTION AND OBJECTIVE: The outcomes of kidney stone surgery have long been focused on stone-free rates and safety, yet patient reported outcomes (PRO) are often lacking. In 2018 the Michigan Urological Surgery Improvement Collaborative (MUSIC)Reducing Operative Complications from Kidney Stones (ROCKS)group initiated a pain optimization pathway using an opioid-free multi-modal pain regimen. This has resulted in a decline in opioid prescription rates after ureteroscopy (86 to 19%). We used a comprehensive PRO system to understand the initiative's impact on patients' experiences of treatment pain and satisfaction. METHODS: MUSIC ROCKS instituted its patient-reported outcomes (PRO) program in 2020 which included an assessment of patient pain (PROMIS Pain Intensity short form and Pain Interference short form) and overall treatment satisfaction (ICIQ-S). This system is automated and distributes questionnaires preoperatively and at 7-10 days and 4-6 weeks following ureteroscopy (URS). We compared patients who were prescribed opiates after URS to those who were not. After adjusting for observed demographic differences (age, gender, pre-stent status, stone location/size, and preoperative pain),we evaluated PRO pain intensity and interference with linear mixed models. A clinically meaningful difference in PROMIS scores is 2.5-3.5 points. Treatment satisfaction scores were compared with Wilcoxon rank tests. RESULTS: A total of 292 patients completed all questionnaires(258 non-opioid and 34 opioid). There was no significant difference between non-opioid and opioid cohorts with regards to age (60 vs 59years), gender (50 vs 53% male), pre-stenting status (76 vs 65%),stone location (64 vs 59% ureteral), and stone size (8.0 vs 7.2 mm).After adjustment, there was no significant difference in preoperative pain intensity scores between the groups at pre-URS (p[0.06), 7-10 days postop (p[0.87), and 4-6 weeks postop (p[0.99, Figure).Pain interference followed a similar pattern, with no significant differences observed at any timepoint. There was no difference in satisfaction scores, as measured both 7-10 days (p[0.46) and 4-6 weeks (p[0.47) after URS.CONCLUSIONS: Rates of opiate prescription have declined after URS in Michigan. Using a novel PRO system, we confirmed that utilization of opioid-free pathways has not resulted in increased pain nor decreased patient satisfaction.

Volume

209

Issue

4S

First Page

e654

Comments

American Urological Association Annual Meeting, April 28 - May 1, 2023, Chicago, IL

40th World Congress of Endourology, WCE 2023, October 23-27, 2023, Jerusalem, Israel

DOI

10.1097/JU.0000000000003294.01

Link to Full Text

Share

COinS